Table 3.
Proportion of dry eye disease patients in each treatment category
| Treatment | Percentage of patients |
|---|---|
| Lubricants | 100% |
| Topical cyclosporine A | 23% |
| Topical anakinra | 23% |
| Topical corticosteroids | 18% |
| Oral tetracycline | 17% |
| Topical autologous-serum | 6% |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.